Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.13 | 0.7 |
mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.7 |
mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |